WebApr 12, 2024 · Petros Pharmaceuticals' mailing address is 1185 AVENUE OF THE AMERICAS 3RD FLOOR, NEW YORK NY, 10036. The official website for the company is … WebThe 52-week high for PTPI is $5.96 and the low is $1.19. Almost 3000 watchers on Stocktwits. Recent Company Updates: I've got a good feeling about what’s ahead for this company. I’m looking for $5-$10, ...
Did you know?
WebPTPI - Read the DD - Check Stocktwits Check Twitter - At Bottom Now. Tiny DO Just Closed, Small Float, SI ~45% , ~100% Util, 389% CTB. Current market cap well below valuation … WebReal-time trade and investing ideas on Petros Pharmaceuticals Inc PTPI from the largest community of traders and investors. ... Not an offer or recommendation by Stocktwits. See disclosure here. Petros Pharmaceuticals Inc NASDAQ Updated Feb 24, 2024 3:59 PM. PTPI 2.17 0.05 (2.25%) 5,627. Watch. Key Data; 52wk Low 1.91; 52wk High 28.80;
WebOct 14, 2024 · October 14, 2024 - 9:00 am. NEW YORK, Oct. 14, 2024-- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announces that it has entered into definitive agreements with the company's largest investor and other existing investors, for the purchase and sale of 3,323,616 shares of … WebPTPI Stock Price - Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, Real-time trade and investing ideas on Petros Pharmaceuticals Inc PTPI from …
WebJul 28, 2024 · July 28, 2024 - 10:27 am. NEW YORK, July 28, 2024 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today confirmed that a press release issued on July 28, 2024 regarding a purported acquisition of the company was fraudulent and not issued by the Company. WebApr 14, 2024 · America’s largest bank, JPMorgan Chase, helped kick off earnings season by knocking the cover off the proverbial ball. 😮 The bank’s first-quarter adjusted earnings of $4.32 per share, topping the $3.41 expected. Profits rose 52% YoY, including an $868 million loss on securities.
WebDec-08-20 04:15PM. Neurotrope, Inc. Completes Independent Spin-off of Neurotrope Bioscience, Inc. and is Renamed Synaptogenix, Inc. PR Newswire. Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor …
WebApr 14, 2024 · Boeing (NYSE: BA) stock is sinking 6% in early trading. The plane manufacturer said that the deliveries of its 737 Max planes may drop meaningfully for a short amount of time because of a problem ... gerards oxon hill mdWebPTPI on StockTwits PTPI on Twitter Petros is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to ED, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and ... christina milian husband cheatsWebFind the latest Petros Pharmaceuticals, Inc. (PTPI) stock quote, history, news and other vital information to help you with your stock trading and investing. gerards place cameron highlands